Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hereditary Sensory and Autonomic Neuropathies × tivozanib × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 2 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Hereditary Sensory and Autonomic Neuropathies 1 Cholangiocarcinoma 1 Bile Duct Neoplasms 1

Interventions

Fulvestrant 2 venetoclax 1 tivozanib 1 ribociclib 1 palbociclib 1 exemestane 1 STX-478 1 Letrozole 1 Irinotecan 1 Gemcitabine 1 CA-4948 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04645160 2026-03-11

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡